Doctors for Cannabis Regulation
Public records show a registered, tax-exempt organization in good standing.
What it says it does
Doctors for Drug Policy Reform (D4DPR) is organized and operated exclusively for charitable and educational purposes to advance public health through evidence-based drug policy reform. The organization educates policymakers, health professionals, and the public on the health effects of drug use and the consequences of drug laws; develops and disseminates scientific, clinical, and policy analyses; and promotes approaches that reduce harm, improve access to treatment, and decrease stigma associated with substance use disorders. D4DPR engages in nonpartisan research, education, and public health advocacy consistent with its mission to improve health outcomes and inform rational, science-driven drug policies
- Income
- $78,082
- Spending
- $27,946
- Reserves
- 22.7 months of spending
- Largest source of income
- donations and private grants, 100%
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
This organization files the short tax form, which does not ask about boards, policies or audits. That is normal for a small charity and is not a mark against it.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (6)
- $226 spent. Expansion of Mission and Public Health Scope During the reporting period, D4DPR continued its transition from a cannabis-focused organization to a broader public health-oriented organization addressing drug policy across all illegal drugs. This expansion enabled the organization to engage a wider range of physicians, scientists, and health professionals; address emerging and complex drug-related public health issues; and contribute to national and international discussions on evidence-based, health-centered drug policy. This work supports the organization's charitable purpose by reducing stigma, improving public understanding, and promoting policies that enhance health outcomes.
- $226 spent. Advancement of Evidence-Based Regulatory Standards D4DPR's work in developing standardized cannabis labeling and warnings continued to influence state-level regulatory frameworks. The International Intoxication Cannabinoid Product Symbol (IICPS), developed with D4DPR involvement, has been adopted in multiple states and is under consideration in additional jurisdictions. Standardized warning language developed by D4DPR has also been adopted at the state level. These efforts contribute to improved consumer awareness, product safety, and consistency in public health messaging.
- $2,495 spent. Education and Dissemination of Scientific and Policy Information D4DPR provided education to healthcare professionals, policymakers, and the public through webinars, written publications, and media engagement. Educational topics included hemp-derived cannabinoids, international drug policy, psychedelics, overdose prevention strategies, and treatment for substance use disorders. The organization produced and disseminated position papers and policy analyses addressing cannabis scheduling, overdose prevention centers, and related issues. Outreach activities included webinars, op-eds, letters to the editor, and media appearances, expanding access to evidence-based information and supporting informed decision-making.
- $15,857 spent. Development of the Health Advocacy Toolkit With grant support, D4DPR developed a comprehensive Health Advocacy Toolkit designed to train healthcare professionals in effective, evidence-based public health advocacy. The toolkit includes policy briefs, fact sheets, and instructional modules on engaging with legislative and regulatory processes, preparing written and oral testimony, and communicating scientific information to policymakers. This initiative increases the capacity of clinicians to participate in public health policy discussions and promotes the dissemination of accurate, science-based information.
- $113 spent. D4DPR launched Physicians for Opioid Settlement Equity (POSE), an initiative aimed at promoting the equitable and evidence-based allocation of opioid settlement funds. This initiative is focused on New York and New Jersey. POSE engages physicians and other healthcare professionals to educate policymakers and the public on effective uses of settlement funds, including treatment access, harm reduction services, and prevention strategies. This initiative advances public health by supporting the allocation of resources toward interventions with demonstrated effectiveness in reducing overdose and improving outcomes for individuals with substance use disorders.
- $266 spent. Coalition Participation and Collaborative Public Health Efforts D4DPR actively participated in national and state-level coalitions focused on drug policy reform and public health. Through these collaborations, the organization contributed medical and scientific expertise to policy discussions, educational initiatives, and public communications. Participation in coalitions enhances the organization's ability to disseminate evidence-based information, amplify its impact, and support coordinated approaches to improving drug policy and health outcomes.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since February 2016.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.